flow trial semaglutide ppt 🚨 Journal Club: Review 🚨 The FLOW Trial, published in The New England Journal of Medicine (May 2024), evaluated the effects of on kidney disease in patients with type Get With the FLOW! in:

Riddle MC, Herman WH

Taking oral semaglutide for weight management is most effective when combined with healthy habits and professional guidance

Tips for managing or identifying thyroid cancer In addition to knowing your family medical history, being able to spot the signs of a thyroid problem is always a good thing

Ozempic (semaglutide), a GLP-1 receptor agonist originally approved for type 2 diabetes, has become one of the most widely prescribed drugs for weight loss in the United States

Semaglutide with methylcobalamin has shown particular promise for addressing the B12 depletion that can occur during extended GLP-1 use